Facilitating Innovative Nuclear Diagnostics Act of 2021
Bill journey · stage 2 of 5
Under committee review
What it doesSummary introduced in house (Jul 16, 2021)
Facilitating Innovative Nuclear Diagnostics Act of 2021
This bill establishes separate payment requirements for diagnostic radiopharmaceuticals under the Medicare prospective payment system for hospital outpatient department services. The bill's requirements apply to diagnostic radiopharmaceuticals that have an average daily cost of $500 or more in 2022 and as adjusted based on a specified fee schedule factor in each year thereafter.
What just happenedJul 19, 2021
Referred to the Subcommittee on Health.
Who’s behind it
- Introduced in HouseJul 16, 2021
- Jul 19, 2021Committee
Referred to the Subcommittee on Health.
Health Subcommittee - Jul 16, 2021Committee
Referred to the Subcommittee on Health.
Health Subcommittee - Jul 16, 2021IntroReferralH11100
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Ways and Means Committee - Jul 16, 2021IntroReferralH11100
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Energy and Commerce Committee - Jul 16, 2021IntroReferralIntro-H
Introduced in House
- Jul 16, 2021IntroReferral1000
Introduced in House